By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.

Close

Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Close

NICE approve skin cancer drugs

Two life-extending drugs used to treat the most dangerous form of skin cancer have been given the go-ahead for use on the NHS.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories 
  • Customised email alerts straight to your inbox (30+ alerts available) 
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units 
or

newsletterpromo